Literature DB >> 1665749

Characterization of endothelin receptors on a human neuroblastoma cell line: evidence for the ETA subtype.

L C Wilkes1, M R Boarder.   

Abstract

1. Specific binding sites for synthetic endothelin (ET) isoforms were studied on intact cells of the SK-N-MC cell line, derived from a human neuroblastoma. 2. [125I]-ET-1 (2.5 x 10(-11) M) specifically bound to a single class of binding sites on these cells (Hill coefficient of 1.06 +/- 0.04, n = 3) with an apparent Kd of 1.4 +/- 0.3 x 10(-9) M and a Bmax of 3.1 +/- 1.0 pmol mg-1 protein. [125I]-ET-3 (2.5 x 10(-11) M), did not specifically bind to SK-N-MC cells. 3. The binding of [125I]-ET-1 was competitively inhibited by other ET isoforms, the order of potency being ET-1 greater than sarafotoxin S6b greater than ET-3. 4. Association of 1 nM [125I]-ET-1 at 37 degrees C reached apparent equilibrium at 60-80 min, with half-maximal binding being achieved at 12 min. 5. Dissociation was measured after both 10 min and 60 min of association with 64% and 30% respectively of specifically bound [125I]-ET-1 dissociating. The actual amounts of [125I]-ET-1 dissociated were similar in both cases. 6. Incubation of [125I]-ET-3 with SK-N-MC cells at 37 degrees C for 60 min did not result in significant degradation of this peptide. However, [125I]-ET-1 was broken down by incubation with SK-N-MC cells, the pattern of degradation of dissociable [125I]-ET-1 (and that found in the supernatant) being different from that of non-dissociable [125I]-ET-1. 7. ET-1 concentration-dependently induced an increase in total inositol phosphate accumulation in subconfluent (but not in confluent) cultures of SK-N-MC cells (EC50 = 6.43 +/- 1.9 x 1010M). ET-3 was without effect. 8. These results show that ET-1 specifically binds to SK-N-MC cells with the characteristics of an ETA receptor. Our earlier finding that adrenal chromaffin cells express an ETB receptor indicates the existence of multiple ET receptor types on neuronal cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665749      PMCID: PMC1908236          DOI: 10.1111/j.1476-5381.1991.tb12499.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.

Authors:  T Sakurai; M Yanagisawa; Y Takuwa; H Miyazaki; S Kimura; K Goto; T Masaki
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

4.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

5.  Abundance of endothelin-3 in rat intestine, pituitary gland and brain.

Authors:  H Matsumoto; N Suzuki; H Onda; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

6.  Endothelin-1 induced contraction of rat aorta: contributions made by Ca2+ influx and activation of contractile apparatus associated with no change in cytoplasmic Ca2+ level.

Authors:  X N Huang; T Hisayama; I Takayanagi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

7.  Characteristics of endothelin-1 and endothelin-3 stimulation of phosphoinositide breakdown differ between regions of guinea-pig and rat brain.

Authors:  M L Crawford; C R Hiley; J M Young
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

8.  Presence of endothelin-1 in porcine spinal cord: isolation and sequence determination.

Authors:  O Shinmi; S Kimura; T Yoshizawa; T Sawamura; Y Uchiyama; Y Sugita; I Kanazawa; M Yanagisawa; K Goto; T Masaki
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

Review 9.  Molecular biology and biochemistry of the endothelins.

Authors:  M Yanagisawa; T Masaki
Journal:  Trends Pharmacol Sci       Date:  1989-09       Impact factor: 14.819

10.  Endothelin stimulates aldosterone biosynthesis by dispersed rabbit adreno-capsular cells.

Authors:  R Morishita; J Higaki; T Ogihara
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

View more
  4 in total

1.  Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists.

Authors:  J R Purkiss; D West; L C Wilkes; C Scott; P Yarrow; G F Wilkinson; M R Boarder
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

2.  Expression of endothelin system in neuroblastic tumors: close association of endothelin-1 and endothelin B receptor expression with differentiation of tumor cells.

Authors:  Nobuo Hoshi; Takashi Sugino; Toshimitsu Suzuki
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

3.  A selective endothelin ETA antagonist, BQ-123, inhibits 125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells.

Authors:  N Kitagawa; K Tsutsumi; M Niwa; S Yamaga; T Anda; H Khalid; A Himeno; K Taniyama; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1994-04       Impact factor: 5.046

Review 4.  Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling.

Authors:  Jinjutha Silpanisong; William J Pearce
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.